Microbial Bioburden on Oral Solid Dosage Forms

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-02-02-2002, Volume 26, Issue 2

Low levels of some microorganisms that are present in oral solid dosage forms are unlikely to present a risk to patients. The amount of water activity in these products can help determine when microbiological testing should be conducted.

Related Content:

Solid/Semi-Solid DosageManufacturingDosage FormsManufacturing, Solid Dosage DrugsManufacturing, Drug ProductsPharmaceutical Technology-02-02-2002
With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs
Using Continuous Processes and Automation to Remove Contamination Risk
Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia